May 13, 2020
Kanazawa University Research: Notorious Cancer Protein Mutations Cooperate to Proliferate Disease
Nov 13, 2019
PMV Pharma Secures $62 Million in Series C Financing To Develop Cancer Drugs Targeting p53
Nov 05, 2019
New Data from Ambry Genetics Show Substantial Increase in Diagnostic Yield, Further Supporting the Routine Use of RNA Genetic Testing for Hereditary Cancer Panels
Oct 01, 2019
Ambry Genetics Makes Scientific Breakthrough and Launches Paired RNA and DNA Testing for Hereditary Cancer
Aug 27, 2019
Ambry Genetics' Data Reveal that Expanding Genetic Testing Guidelines Could Identify More Patients with Increased Risks of Cancer
Aug 05, 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
Jul 04, 2019
Kanazawa University Research: Cancer Genes and the Tumor Milieu
Apr 03, 2019
Results From Combination of APR-246 with Immuno-Oncology Agents Presented at the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta
Mar 25, 2019
Ambry Genetics to Develop Custom Assays Targeted to Patients with Hereditary Ovarian Cancer
Mar 25, 2019
Aprea Therapeutics Appoints Dr. Eyal C. Attar as Chief Medical Officer
Feb 27, 2019
Aprea Therapeutics Adds New Investor to Series C Financing
Dec 19, 2018
Ascentage Pharma Announces Strategic Collaboration with Genor Biopharma
Dec 10, 2018
New Study Published in Journal of Clinical Oncology Supports Universal Genetic Testing for all Breast Cancer Patients
Nov 30, 2018
Aprea Therapeutics Closes EUR 50 Million Financing
May 30, 2018
Miraculous Small Molecules - One Step Further towards Helping Cancer Prevention and Healthy Longevity
Mar 07, 2018
Assemblywomen Autumn Burke and Marie Waldron Demand More Genetic Testing for Women with a High Risk of Ovarian and Breast Cancer
Mar 06, 2018
FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
Jan 25, 2018
MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene Therapy
Jan 04, 2018
Aprea Therapeutics Announces Presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco
Dec 05, 2017
Multigene Genetic Testing Improves Identification and Management of Hereditary Cancer Risk for Breast Cancer Patients and Their Families